MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Novel presentation of PRRT2 with paroxysmal dystonia and responsive to carbidopa/levodopa.

    J. Cremin-Endes, M. Walsh, M. Higginson, N. Hack (San Diego, USA)

    Objective: Present a novel case of PRRT2 positive PKD presenting with paroxysmal dystonia that responded to treatment with carbidopa levodopa. First report in the literature.…
  • 2025 International Congress

    Atypical Onset and Presentation of Rare DYT30-VPS16 Dystonia

    Y. Trufanov, E. Tsoma, M. Trishchynska, N. Khanenko, G. Chupryna, V. Sereda, A. Ovchynnykova (Prague, Czech Republic)

    Objective: To provide a description of a young patient with atypical onset and presentation of rare DYT30-VPS16 dystonia. Background: To date, 44 patients from 31…
  • 2025 International Congress

    A Case of SGCE Myoclonus-Dystonia diagnosed in a 70-Year-Old Male

    V. Mazo, P. Atit, N. Shneyder, N. Rincon-Flores (Tampa, USA)

    Objective: N/A Background: SGCE myoclonus-dystonia (SGCE-M-D) is a movement disorder characterized by myoclonus and dystonia, primarily affecting the neck, trunk, and upper limbs. Patients may…
  • 2025 International Congress

    Deep Brain Stimulation in a Patient with Dystonia-Parkinsonism Secondary to a c.609G>A PLA2G6-Associated Neurodegeneration Variant

    J. Patino, M. Christie (Houston, USA)

    Objective: To describe a rare likely pathogenic variant of the PLA2G6 protein and its response to deep brain stimulation (DBS). Background: PLA2G6-associated neurodegeneration (PLAN) can…
  • 2025 International Congress

    National Survey of DYT/PARK-GCH1 (Segawa Disease) in Japan

    K. Hoshino, M. Kawai, Y. Nagao, M. Nozaki, Y. Yatomi, Y. Hirano, M. Fukumizu, I. Kawahata, H. Shintaku, K. Kimura, M. Hayashi (Osaka, Japan)

    Objective: To clarify clinical features of Segawa Disease (SD) in Japan. Background: Prof Segawa discovered SD 50 years ago, and GCH-1 gene mutations were linked…
  • 2025 International Congress

    The Role of the Immune System in Dystonia: Insights from HLA genotyping

    M. Lindloge, L. Scorr, B. Laabs, D. Ellinghaus, A. Franke, H. Jinnah, C. Klein, K. Lohmann (Altanta, USA)

    Objective: To characterize the association between Human Leukocyte Antigen (HLA) alleles and dystonia. Background: Dystonia is widely recognized to have great etiologic heterogeneity. A complex…
  • 2025 International Congress

    Case Report of a Brazilian Family With New VUS for PLAN

    M. Medeiros, M. Augustin (Porto Alegre, Brazil)

    Objective: The aim is to describe a Brazilian family with new VUS of PLA2G6 in two brothers with clinical symptoms of PLAN. Background: PLAN is…
  • 2025 International Congress

    When Dystonia mimics Multiple Sclerosis : A Familial case series of GCH1 misdiagnosis

    B. Perraud, I. Beaulieu-Boire (Sherbrooke, Canada)

    Objective: To describe phenotypic variability associated with a GCH1 mutation and increase clinical suspicion in patients with atypical phenotypes. Background: Dopa-responsive dystonia (DRD) is a genetic disorder most commonly…
  • 2025 International Congress

    Bilateral Pallidal Deep Brain Stimulation in Secondary Dystonia in Louis-Bar-Syndrome Patients – A Report of Two Cases-

    N. Warneke, I. Claus, V. Zentsch, W. Stummer (Münster, Germany)

    Objective: Deep Brain Stimulation (DBS) is an established treatment for various movement disorders, including primary dystonia. The effect in secondary dystonia is less well studied.…
  • 2025 International Congress

    Biallelic Variants in ACER3 Encoding Alkaline Ceramidase 3 Cause Infantile- and Early-Childhood-Onset Neurodegeneration with Progressive Leukodystrophy

    R. Kaiyrzhanov, A. Study Group, H. Houlden, R. Maroofian (Shymkent, Kazakhstan)

    Objective: To delineate the clinical phenotype and molecular spectrum of alkaline ceramidase 3 -related disease (ACER3-RD) by characterizing 60 patients from 55 independent families. Background:…
  • « Previous Page
  • 1
  • …
  • 236
  • 237
  • 238
  • 239
  • 240
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley